Cargando…
LncRNA in tumorigenesis of non-small-cell lung cancer: From bench to bedside
Lung cancer has been one of the leading causes of cancer-related death worldwide, and non-small-cell lung cancer (NSCLC) accounts for the majority of lung cancer morbidity, yet the pathogenesis of NSCLC has not been fully elucidated. Recently, long-chain non-coding RNA (lncRNA) has attracted widespr...
Autores principales: | Hu, Qin, Ma, Huiyun, Chen, Hongyu, Zhang, Zhouwei, Xue, Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376075/ https://www.ncbi.nlm.nih.gov/pubmed/35963868 http://dx.doi.org/10.1038/s41420-022-01157-4 |
Ejemplares similares
-
Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma
por: Hu, Qin, et al.
Publicado: (2022) -
Biomarkers for Non-Small Cell Lung Cancer: From the Bench to the Bedside
por: de Mello, Ramon Andrade, et al.
Publicado: (2020) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022) -
Novel lncRNA UPLA1 mediates tumorigenesis and prognosis in lung adenocarcinoma
por: Han, Xiaoyang, et al.
Publicado: (2020) -
Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer
por: Hu, Qin, et al.
Publicado: (2022)